• Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2

  • Dec 6 2023
  • Duración: 23 m
  • Podcast

Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2  Por  arte de portada

Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2

  • Resumen

  • Robert Mitchell-Thain, CEO of the PBC Foundation, Edinburgh, UK and Kath Houghton, Autoimmune Specialist Nurse, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK, discuss their ‘Primary Biliary Cholangitis (PBC) highlights from EASL 2023’ in this podcast.

    Their discussion covers the relationship between initial symptoms and disease trajectory, the association of biochemical control and outcomes in PBC, and the impact and assessment of patient reported outcomes.

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Primary Biliary Cholangitis (PBC): Highlights from EASL 2023 - Part 2

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.